ASTRAZENECA PHARMACEUTICALS LP

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 81174
 
  
 
C07K PEPTIDES 33103
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1039
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 3151
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C08H DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS 114
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9884092 Methods for treating diabetes and reducing body weightMay 31, 16Feb 06, 18[A61K, C07K]
9593154 Engineered polypeptides having enhanced duration of actionMar 28, 13Mar 14, 17[A61K, C07K]
9453063 Hybrid polypeptides with selectable propertiesMar 03, 14Sep 27, 16[A61K, C07K]
9382304 Engineered polypeptides having enhanced duration of action with reduced immunogenicityJul 03, 12Jul 05, 16[A61K, C12N, C07K]
9248240 Formulation delivery deviceOct 14, 09Feb 02, 16[A61M]
9249181 C-terminal amidation of polypeptidesSep 08, 11Feb 02, 16[C07D, C07C, C07K]
9217022 GLP-1 receptor agonist compounds having stabilized regionsJul 27, 11Dec 22, 15[A61K, C07K]
9133260 GIP analog and hybrid polypeptides with selectable propertiesMar 25, 13Sep 15, 15[A61K, A61P, C07K]
9034819 Method of lowering cholesterol and triglycerides by administering exendinsFeb 22, 13May 19, 15[A61K]
8951962 Modified exendins and exendin agonistsMay 17, 13Feb 10, 15[A61K, C12N, A61P, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0346,357 SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERSAbandonedAug 11, 16Dec 01, 16[A61K]
2016/0120,950 Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAbandonedOct 30, 15May 05, 16[A61K]
2015/0238,568 EXENDINS TO LOWER CHOLESTEROL AND TRIGLYCERIDESAbandonedMay 13, 15Aug 27, 15[A61K]
2015/0231,204 PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAMEAbandonedNov 12, 14Aug 20, 15[A61K]
2015/0157,725 TRANSMUCOSAL DELIVERY OF PEPTIDES AND PROTEINSAbandonedDec 15, 14Jun 11, 15[A61K]
2015/0150,948 METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHTAbandonedNov 25, 14Jun 04, 15[A61K]
2015/0133,373 TRANSMUCOSAL DELIVERY OF ENGINEERED POLYPEPTIDESAbandonedMar 28, 13May 14, 15[A61K]
2015/0111,246 SITE-SPECIFIC ENZYMATIC MODIFICATION OF EXENDINS AND ANALOGS THEREOFAbandonedApr 23, 13Apr 23, 15[C12P, C07K]
2015/0111,824 Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAbandonedOct 28, 14Apr 23, 15[A61K]
2015/0080,307 EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITYAbandonedNov 21, 14Mar 19, 15[C07K]
2015/0080,308 Formulations and Uses of Exendins and Exendin Agonist AnalogsAbandonedNov 25, 14Mar 19, 15[A61K, C07K]
2015/0056,285 SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERSAbandonedOct 27, 14Feb 26, 15[A61K]
2014/0371,148 PEPTIDE-PEPTIDASE INHIBITOR CONJUGATES AND METHODS OF USING SAMEAbandonedJun 18, 14Dec 18, 14[A61K]
2014/0249,076 AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENHANCING MOIETIESAbandonedOct 17, 12Sep 04, 14[A61K]
2014/0249,077 GEL COMPOSITIONSAbandonedJun 08, 12Sep 04, 14[A61K]
2014/0220,134 METHOD FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATION OF GLP-1 RECEPTOR AGONISTSAbandonedJun 21, 12Aug 07, 14[A61K]
2014/0221,282 LONG DURATION DUAL HORMONE CONJUGATESAbandonedMay 24, 12Aug 07, 14[A61K]
2014/0221,287 Amylin Peptides and Derivatives and Uses ThereofAbandonedMay 24, 12Aug 07, 14[C07K]
2014/0200,183 TREATMENT OF CARDIAC ARRHYTHMIASAbandonedMar 21, 14Jul 17, 14[A61K]
2014/0162,943 N-TERMINUS CONFORMATIONALLY CONSTRAINED GLP-1 RECEPTOR AGONIST COMPOUNDSAbandonedJan 28, 14Jun 12, 14[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.